Glucose 5% Basi (Glucose)

Glucose 5% Basi is used in several clinical situations where a rapid source of carbohydrate or fluid replacement is needed.

• Treatment of acute hypoglycemia in patients unable to take oral glucose.
• Component of parenteral nutrition regimens to provide caloric support.
• Fluid and electrolyte replacement during surgery or trauma.
• Dilution medium for intravenous drug admixtures.
• Maintenance of blood glucose levels during prolonged fasting.
• Support for patients with metabolic disorders requiring controlled glucose infusion.

Glucose 5% Basi may be associated with a range of adverse reactions, most of which are mild and transient.

Common

• Mild hyperglycemia when administered in excess.
• Local irritation or pain at the infusion site.
• Nausea or vomiting related to rapid glucose infusion.
• Electrolyte shifts, particularly decreased serum potassium.
• Transient headache due to rapid osmotic changes.
• Mild metabolic acidosis in patients with impaired renal function.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Fluid overload causing pulmonary edema.
• Allergic reactions such as urticaria or anaphylaxis.
• Hyperosmolar hyperglycemic state in susceptible patients.
• Hypoglycemia if glucose infusion is abruptly discontinued after prolonged use.
• Severe electrolyte disturbances such as hypernatremia or hypocalcemia.

When prescribing Glucose 5% Basi, clinicians should consider several precautionary measures to ensure safe administration and minimize complications.

• Assess baseline blood glucose levels and continue periodic monitoring during the infusion to avoid both hyperglycemia and hypoglycemia.
• Monitor cumulative fluid input and output, particularly in patients with congestive heart failure or impaired renal function, to prevent fluid overload.
• Adjust the infusion rate based on the patient’s electrolyte status, especially potassium and sodium levels, to reduce the risk of shifts.
• Employ strict aseptic technique when accessing the intravenous line to minimize the risk of catheter-associated bloodstream infections.
• Avoid rapid bolus administration unless clinically indicated, as sudden glucose spikes can precipitate metabolic disturbances.
• Confirm compatibility with other intravenous drugs before co‑administration, as incompatibility may cause precipitation or loss of efficacy.
• Evaluate pregnancy status; current safety information is limited, so use only when the potential benefit justifies the potential risk.

Glucose 5% Basi can interact with other medications or clinical conditions, influencing its safety and effectiveness.

Avoid

• Co‑administration with insulin infusions without appropriate dose adjustments, which may cause severe hypoglycemia.
• Simultaneous infusion of potassium chloride solutions, as rapid glucose delivery can increase serum potassium and precipitate arrhythmias.

Use with caution

• Concurrent use of diuretics that affect electrolyte balance; monitor potassium and sodium levels closely.
• Administration with beta‑adrenergic agonists, which may enhance glycogenolysis and alter glucose requirements.
• Use in patients receiving total parenteral nutrition containing other carbohydrate sources; adjust total glucose load to prevent hyperglycemia.